Publication Name	World Journal of Diabetes
Manuscript ID	92711
Country	China

Received	2024-02-05 09:29
Peer-Review Started	2024-02-05 09:29
To Make the First Decision
Return for Revision	2024-04-10 23:27
Revised	2024-04-26 07:50
Second Decision	2024-09-30 06:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-08 08:43
Articles in Press	2024-10-08 08:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-23 10:58
Publish the Manuscript Online	2024-11-30 03:48

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Basic Study
Article Title	Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress
Manuscript Source	Unsolicited Manuscript
All Author List	Zhi-Min Lin, Han-Yuan Gao, Shu-Han Shi and Yue-Ting Li
ORCID	Author(s) ORCID Number Yue-Ting Li http://orcid.org/0000-0002-7835-7777
Funding Agency and Grant Number
Corresponding Author	Yue-Ting Li, FAASLD, BSc, MD, Academic Editor, Department of Nephrology, The Second Affiliated Hospital of Fujian Medical University, No. 34 Zhongshan North Road, Licheng District, Quanzhou 362000, Fujian Province, China. yuetingli20230125@163.com
Key Words	Mizagliflozin; Sodium-glucose cotransport protein 1; Diabetic nephropathy; Mesangial cells
Core Tip	Diabetic nephropathy is a common and serious complication of diabetes, characterized by the accumulation of extracellular matrix in the renal units. Mizagliflozin can improve diabetic nephropathy impairment by inhibiting neural sodium-glucose cotransport protein 1, inflammation, and oxidative stress. Its functions are regarded as positive regulators of inflammation and oxidative stress. These findings offer new treatment methods targeting sodium-glucose cotransport protein 1 inhibitors for diabetic kidney disease.
Publish Date	2024-11-30 03:48
Citation	<p>Lin ZM, Gao HY, Shi SH, Li YT. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. <i>World J Diabetes</i> 2025; 16(1): 92711</p>
URL	https://www.wjgnet.com/1948-9358/full/v16/i1/92711.htm
DOI	https://dx.doi.org/10.4239/wjd.v16.i1.92711

Full Article (PDF)	WJD-16-92711-with-cover.pdf
The ARRIVE Guidelines	92711-The-ARRIVE-Guidelines.pdf
Manuscript File	92711_Auto_Edited_083839.docx
Answering Reviewers	92711-answering-reviewers.pdf
Audio Core Tip	92711-audio.m4a
Biostatistics Review Certificate	92711-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	92711-conflict-of-interest-statement.pdf
Copyright License Agreement	92711-copyright-assignment.pdf
Institutional Animal Care and Use Committee Approval Form or Document	92711-institutional-animal-care-and-use-committee-statement.pdf
Institutional Review Board Approval Form or Document	92711-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate	92711-non-native-speakers.pdf
Peer-review Report	92711-peer-reviews.pdf
Journal Editor-in-Chief Review Report	92711-journal-editor-in-chief.pdf
Scientific Misconduct Check	92711-scientific-misconduct-check.png
Scientific Editor Work List	92711-scientific-editor-work-list.pdf
CrossCheck Report	92711-crosscheck-report.pdf